Published in Ann Thorac Surg on October 04, 2012
Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg (2014) 0.87
Predictive Factors for Severe Outcomes in Ischemic Colitis. Gut Liver (2015) 0.80
The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes. Ann Thorac Surg (2016) 0.78
Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index. Ann Thorac Surg (2016) 0.75
Invited commentary. Ann Thorac Surg (2012) 0.75
Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery. J Am Heart Assoc (2017) 0.75
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Causal diagrams for epidemiologic research. Epidemiology (1999) 19.48
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 12.45
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
Obesity in general elective surgery. Lancet (2003) 7.22
Increases in morbid obesity in the USA: 2000-2005. Public Health (2007) 4.33
State-level estimates of annual medical expenditures attributable to obesity. Obes Res (2004) 3.20
Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med (1998) 2.58
Moderate and severe obesity have large differences in health care costs. Obes Res (2004) 2.43
STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg (2010) 2.25
The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg (2009) 1.99
Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg (2004) 1.97
A comparison of the perioperative morbidity in total joint arthroplasty in the obese and nonobese patient. Clin Orthop Relat Res (1993) 1.45
Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg (1991) 1.43
Impact of body mass index on radical cystectomy. J Urol (2004) 1.31
Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg (2004) 1.17
The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians. Surg Endosc (2009) 1.16
Body mass index as a correlate of postoperative complications and resource utilization. Am J Med (1997) 1.10
Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients. Ann Surg (2009) 1.01
Obesity does not increase complications after anatomic resection for non-small cell lung cancer. Ann Thorac Surg (2007) 0.99
Impact of obesity on resource utilization for general surgical procedures. Ann Surg (2005) 0.99
Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol (1990) 0.95
Determinants of outcomes in pancreatic surgery and use of hospital resources. J Surg Oncol (2011) 0.91
Determinants of resource utilization and outcomes in laparoscopic Roux-en-Y gastric bypass: a multicenter analysis of 14,251 patients. Surg Endosc (2011) 0.81
Obesity and incremental hospital charges among patients with and without diabetes in the United States. Value Health (2011) 0.81
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg (2011) 5.14
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg (2010) 4.23
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med (2011) 3.58
Management of primary pulmonary artery sarcomas. Ann Thorac Surg (2009) 3.37
Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg (2006) 3.32
Genetic ancestry in lung-function predictions. N Engl J Med (2010) 3.30
The landscape of recombination in African Americans. Nature (2011) 3.06
Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg (2009) 3.06
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg (2004) 2.62
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2009) 2.35
Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg (2010) 2.31
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol (2005) 2.30
STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg (2010) 2.25
Risk factors for morbidity after lobectomy for lung cancer in elderly patients. Ann Thorac Surg (2009) 2.19
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg (2004) 2.18
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17
Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol (2014) 2.17
Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg (2007) 2.17
Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg (2012) 2.09
Treatment outcomes of resected esophageal cancer. Ann Surg (2002) 2.03
Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg (2007) 2.01
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (2007) 1.96
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Care models and associated outcomes in congenital heart surgery. Pediatrics (2011) 1.90
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg (2011) 1.80
Association of center volume with mortality and complications in pediatric heart surgery. Pediatrics (2012) 1.73
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol (2010) 1.70
Antagonists selective for estrogen receptor alpha. Endocrinology (2002) 1.70
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem (2004) 1.67
Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. Ann Thorac Surg (2007) 1.66
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg (2002) 1.64
Should I lie about my work hours this week? J Am Coll Surg (2005) 1.60
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg (2013) 1.59
Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58
Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res (2008) 1.55
Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg (2010) 1.54
Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg (2006) 1.52
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet (2012) 1.52
The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer (2004) 1.47
A three-part intervention to change the use of hormone replacement therapy in response to new evidence. Ann Intern Med (2004) 1.47
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys (2003) 1.45
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. J Med Chem (2004) 1.43
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol (2004) 1.43
Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg (2012) 1.42
Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev (2003) 1.42
Regional variation in patient risk factors and mortality after coronary artery bypass grafting. Ann Thorac Surg (2011) 1.42
A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res (2003) 1.36
Living-related transplantation of an ectopic pelvic kidney. Transplantation (2004) 1.35
Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol (2003) 1.33
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res (2003) 1.32
Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. Ann Thorac Surg (2010) 1.32
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res (2004) 1.32
A study of transportability of an existing smoking status detection module across institutions. AMIA Annu Symp Proc (2012) 1.31
Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. Mol Cell (2004) 1.24
Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg (2011) 1.23
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg (2002) 1.23
Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. Ann Thorac Surg (2006) 1.19
Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes (2009) 1.18
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg (2002) 1.18
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg (2011) 1.18
Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set. Lung Cancer (2012) 1.15
Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect (2008) 1.13
Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. J Thorac Cardiovasc Surg (2009) 1.12
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg (2007) 1.11
Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg (2010) 1.09
Recurrent bronchogenic cyst causing recurrent laryngeal nerve palsy. Eur J Cardiothorac Surg (2002) 1.07
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys (2003) 1.07
Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J Med Chem (2003) 1.07
Improving documentation of patient acuity level using a progress note template. J Am Coll Surg (2004) 1.06
Outcomes of tracheobronchial stents in patients with malignant airway disease. Ann Thorac Surg (2005) 1.06
Thymoma: benign appearance, malignant potential. Oncologist (2006) 1.05
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Physiologic properties of small intestine submucosa. J Surg Res (2005) 1.04
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer (2008) 1.03
Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis (2008) 1.03
Cosmopolitan and ethnic-specific replication of genetic risk factors for asthma in 2 Latino populations. J Allergy Clin Immunol (2011) 1.03
Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base. Clin Lung Cancer (2005) 1.01